REPORTS

Let’s Pullulate and Expand Your Business

Malaria Drugs Market - Global Professional Analysis and Forecast to 2026

Feb 29, 2020  |  187 PAGES  |  REPORT CODE: CMM269325
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Malaria Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.8% during the forecast period.

This report presents the market size and development trends by detailing the Malaria Drugs market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Malaria Drugs market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Malaria Drugs industry and will help you to build a panoramic view of the industrial development.

Malaria Drugs Market, By Type:

  • Aryl Aminoalcohol Compounds

  • Antifolate Compounds

  • Artemisinin Compounds

Malaria Drugs Market, By Application:

  • Prevention

  • Treatment

  • Other

Some of the leading players are as follows:

  • Cipla

  • Kunming Pharmaceutical

  • Sanofi Aventis

  • Ajanta Pharma

  • Roche

  • Guilin Pharmaceutical

  • Mylan Labs

  • IPCA Laboratories

  • Novartis

  • GlaxoSmithKline

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Malaria Drugs Market: Technology Type Analysis

  • 4.1 Malaria Drugs Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Malaria Drugs Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Aryl Aminoalcohol Compounds

    • 4.3.2 Antifolate Compounds

    • 4.3.3 Artemisinin Compounds

5 Malaria Drugs Market: Product Analysis

  • 5.1 Malaria Drugs Product Market Share Analysis, 2018 & 2026

  • 5.2 Malaria Drugs Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Malaria Drugs Market: Application Analysis

  • 6.1 Malaria Drugs Application Market Share Analysis, 2018 & 2026

  • 6.2 Malaria Drugs Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Prevention

    • 6.3.2 Treatment

    • 6.3.3 Other

7 Malaria Drugs Market: Regional Analysis

  • 7.1 Malaria Drugs Regional Market Share Analysis, 2018 & 2026

  • 7.2 Malaria Drugs Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Cipla

    • 9.1.1 Cipla Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Kunming Pharmaceutical

    • 9.2.1 Kunming Pharmaceutical Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Sanofi Aventis

    • 9.3.1 Sanofi Aventis Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Ajanta Pharma

    • 9.4.1 Ajanta Pharma Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Roche

    • 9.5.1 Roche Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Guilin Pharmaceutical

    • 9.6.1 Guilin Pharmaceutical Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Mylan Labs

    • 9.7.1 Mylan Labs Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 IPCA Laboratories

    • 9.8.1 IPCA Laboratories Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Novartis

    • 9.9.1 Novartis Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 GlaxoSmithKline

    • 9.10.1 GlaxoSmithKline Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

 

The List of Tables and Figures (Totals 104 Figures and 125 Tables)

  • Figure Aryl Aminoalcohol Compounds Malaria Drugs market, 2015 - 2026 (USD Million)

  • Figure Antifolate Compounds Malaria Drugs market, 2015 - 2026 (USD Million)

  • Figure Artemisinin Compounds Malaria Drugs market, 2015 - 2026 (USD Million)

  • Figure Prevention market, 2015 - 2026 (USD Million)

  • Figure Treatment market, 2015 - 2026 (USD Million)

  • Figure Other market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Malaria Drugs market, by country, 2015 - 2026 (USD Million)

  • Table North America Malaria Drugs market, by type, 2015 - 2026 (USD Million)

  • Table North America Malaria Drugs market, by product, 2015 - 2026 (USD Million)

  • Table North America Malaria Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Malaria Drugs market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Malaria Drugs market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Malaria Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Malaria Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Canada Malaria Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Canada Malaria Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Europe Malaria Drugs market, by country, 2015 - 2026 (USD Million)

  • Table Europe Malaria Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Europe Malaria Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Europe Malaria Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Malaria Drugs market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Malaria Drugs market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Malaria Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Malaria Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Germany Malaria Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Germany Malaria Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Malaria Drugs market, by type, 2015 - 2026 (USD Million)

  • Table France Malaria Drugs market, by product, 2015 - 2026 (USD Million)

  • Table France Malaria Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Malaria Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Italy Malaria Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Italy Malaria Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Malaria Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Spain Malaria Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Spain Malaria Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Malaria Drugs market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Malaria Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Malaria Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Malaria Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Malaria Drugs market, by type, 2015 - 2026 (USD Million)

  • Table China Malaria Drugs market, by product, 2015 - 2026 (USD Million)

  • Table China Malaria Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Malaria Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Japan Malaria Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Japan Malaria Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Malaria Drugs market, by type, 2015 - 2026 (USD Million)

  • Table India Malaria Drugs market, by product, 2015 - 2026 (USD Million)

  • Table India Malaria Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Malaria Drugs market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Malaria Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Malaria Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Malaria Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Malaria Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Malaria Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Malaria Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Malaria Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Malaria Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Malaria Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Malaria Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Malaria Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Malaria Drugs market, by application, 2015 - 2026 (USD Million)

  • Table MEA Malaria Drugs market, by country, 2015 - 2026 (USD Million)

  • Table MEA Malaria Drugs market, by type, 2015 - 2026 (USD Million)

  • Table MEA Malaria Drugs market, by product, 2015 - 2026 (USD Million)

  • Table MEA Malaria Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Malaria Drugs market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Malaria Drugs market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Malaria Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Malaria Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Malaria Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Malaria Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Cipla Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Kunming Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi Aventis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Ajanta Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Roche Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Guilin Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mylan Labs Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table IPCA Laboratories Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top